Oter-López, B <br/><br/>
Induction of Autoantibodies and Autoimmune Diseases in Patients with Psoriasis Receiving Tumor Necrosis Factor Inhibitors.  [electronic resource] 

 -  Actas dermo-sifiliograficas  Jun 2017 
 - 445-456 p.  digital 
<br/><br/> Publication Type: Journal Article 
<br/><br/><label>ISSN: </label>1578-2190 
<br/><br/><label>Standard No.: </label>10.1016/j.ad.2016.12.014  doi 
<br/><br/><label>Subjects--Topical Terms: </label><br/>Adalimumab--adverse effects<br/>Adolescent<br/>Adult<br/>Aged<br/>Antibodies, Antinuclear--biosynthesis<br/>Antigens, Nuclear--immunology<br/>Antirheumatic Agents--adverse effects<br/>Autoantigens--immunology<br/>Autoimmune Diseases--blood<br/>DNA--immunology<br/>Etanercept--adverse effects<br/>Female<br/>Follow-Up Studies<br/>Humans<br/>Male<br/>Middle Aged<br/>Psoriasis--drug therapy<br/>Retrospective Studies<br/>Tumor Necrosis Factor-alpha--antagonists & inhibitors<br/>Young Adult